Rituximab is associated with improved survival for aggressive B cell CNS lymphoma
Gregory, G., Arumugaswamy, A., Leung, T., Chan, K.-L., Abikhair, M., Tam, C., Bajel, A., Cher, L., Grigg, A., Ritchie, D., Opat, S.Volume:
15
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/not032
Date:
August, 2013
File:
PDF, 149 KB
english, 2013